US Stock MarketDetailed Quotes

BCTX BriaCell Therapeutics

Watchlist

0.730
-0.059-7.52%

Close Nov 22 16:00 ET

0.719
-0.011-1.47%

Post 16:00 ET

26.40MMarket Cap-2516P/E (TTM)

BriaCell Therapeutics Stock Forum

Trytosaveabit

Nov 21 06:53

Update

$BriaCell Therapeutics (BCTX.US)$ Reuters
2 mins ago
Briacell Announces First Patient Dosed With Bria-Ots™ in Metastatic Breast Cancer Study

Willy 5150

Nov 19 08:58

Time to Scale Into This.

$BriaCell Therapeutics (BCTX.US)$ Low risk at these prices. I can place my SLO below 0.45 or 0.40. This is very oversold and showing Bullish Divergence imo.

103991611

Nov 14 13:22

$BriaCell Therapeutics (BCTX.US)$ ok what's up why it fall

Trytosaveabit

Nov 8 06:53

Update

$BriaCell Therapeutics (BCTX.US)$ BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference
1 MINUTE AGO, 7:50 AM EST
VIA GLOBENEWSWIRE
BriaCell's clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer activity in preclinical models
Novel therapy activates both innate and adaptive immune systems
Proof of concept Phase 1/2 Study of Bria-BRES™ in met...

Trytosaveabit

Oct 22 06:56

Update

$BriaCell Therapeutics (BCTX.US)$ BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
3 MINUTES AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
55% of BriaCell patients1 remained alive one year since enrollment in BriaCell's Phase 2 study, markedly exceeding the survival rate of current standard of care for similar patients
Multiple outperforming patients with overall survival of over 2 years
Survival benefit observed even in heavily pre-treated patients w...

Jaguar8

Oct 22 06:51

NEWS

$BriaCell Therapeutics (BCTX.US)$
BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data
▪️55% of BriaCell patients1 remained alive one year since enrollment in BriaCell's Phase 2 study, markedly exceeding the survival rate of current standard of care for similar patients
▪️Multiple outperforming patients with overall survival of over 2 years
▪️Survival benefit observed even in heavily pre-treated patients who failed treatment with checkpoint inhib...

Willy 5150

Oct 17 20:14

Today's Price Action 0.79 - 0.85

$BriaCell Therapeutics (BCTX.US)$ This is the area of interest for me, and today's candle was green, but I still need to see more PA, and see if this is going to give me any bullish patterns. Might start scaling back into this again imo.

Trytosaveabit

Oct 15 06:56

Update

$BriaCell Therapeutics (BCTX.US)$ BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
5 MINUTES AGO, 7:50 AM EDT
VIA GLOBENEWSWIRE
35 sites active and enrolling in pivotal Phase 3 study of Bria-IMT™ combination with immune check point inhibitor in metastatic breast cancer (MBC)
Primary endpoint is overall survival (OS) with Bria-IMT™ regimen plus Check Point Inhibitor (CPI) vs treatment of physician's choice
Interim data analysis planned at 144 eve...

Willy 5150

Oct 14 17:56

0.79 - 0.85 Area On Watch.

$BriaCell Therapeutics (BCTX.US)$ If that holds, and shows bullish candle patterns, I'll start scaling in.... just for a low risk swing to the upside imo.